What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Bioinformatics, UniProt, Annotation, Database and Computational biology.
His Bioinformatics research includes themes of Proteomics Standards Initiative, Human proteome project, Data model and Controlled vocabulary, Information retrieval.
His UniProt study combines topics in areas such as Sequence database, Protein sequencing and Manual annotation.
Rolf Apweiler combines subjects such as Set, The Internet and Documentation with his study of Annotation.
The concepts of his Database study are interwoven with issues in International Protein Index and Interface.
His work deals with themes such as PeptideAtlas, Proteome, Proteomics and Membrane protein, which intersect with Computational biology.
His most cited work include:
- UniProt: the Universal Protein knowledgebase (5074 citations)
- UniProt: A hub for protein information (3361 citations)
- The Universal Protein Resource (UniProt) (3265 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Computational biology, Bioinformatics, UniProt, Proteome and Annotation.
His work in the fields of Computational biology, such as Systems biology, overlaps with other areas such as InterPro.
His Bioinformatics research includes elements of Controlled vocabulary and Molecular Sequence Annotation.
His studies deal with areas such as Sequence database and Protein sequencing as well as UniProt.
As part of the same scientific family, Rolf Apweiler usually focuses on Proteome, concentrating on Proteomics and intersecting with Data science.
His Annotation research is multidisciplinary, incorporating elements of Set, Resource, The Internet, World Wide Web and Information retrieval.
He most often published in these fields:
- Computational biology (28.32%)
- Bioinformatics (25.09%)
- UniProt (21.51%)
What were the highlights of his more recent work (between 2010-2021)?
- Bioinformatics (25.09%)
- Computational biology (28.32%)
- UniProt (21.51%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Bioinformatics, Computational biology, UniProt, Annotation and Data science.
His biological study spans a wide range of topics, including Petabyte, Emerging technologies, The Internet and Library science.
His Computational biology research is multidisciplinary, incorporating perspectives in Proteome, Genetics and Drosophila melanogaster.
His studies in Proteome integrate themes in fields like Proteomics, Gene and Genome.
His UniProt study integrates concerns from other disciplines, such as Set and Database.
His Annotation research incorporates themes from Ontology, Controlled vocabulary, World Wide Web, Identifier and Molecular Sequence Annotation.
Between 2010 and 2021, his most popular works were:
- UniProt: A hub for protein information (3361 citations)
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination (1926 citations)
- Activities at the Universal Protein Resource (UniProt) (1597 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in UniProt, Annotation, Computational biology, Bioinformatics and World Wide Web.
His research in UniProt intersects with topics in Web service, Information resource and Database.
His Annotation study combines topics from a wide range of disciplines, such as Controlled vocabulary and Ontology.
Rolf Apweiler interconnects Proteomics Standards Initiative, Protein database, PeptideAtlas and Universal Protein Resource in the investigation of issues within Computational biology.
His Bioinformatics research incorporates elements of Petabyte, Cloud computing, Interoperability and System integration.
The World Wide Web study combines topics in areas such as Identifier, Proteome, DNA sequencing and Accession number.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
